Biblio

Export 1636 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
M. Jin, Shepardson, N., Yang, T., Chen, G., Walsh, D., and Selkoe, D. J., “Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration.”, Proc Natl Acad Sci U S A, vol. 108, no. 14, pp. 5819-24, 2011.
R. Cascella, Evangelisti, E., Bigi, A., Becatti, M., Fiorillo, C., Stefani, M., Chiti, F., and Cecchi, C., “Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload.”, J Alzheimers Dis, vol. 60, no. 3, pp. 923-938, 2017.
R. Cascella, Evangelisti, E., Bigi, A., Becatti, M., Fiorillo, C., Stefani, M., Chiti, F., and Cecchi, C., “Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload.”, J Alzheimers Dis, vol. 60, no. 3, pp. 923-938, 2017.
R. Cascella, Evangelisti, E., Bigi, A., Becatti, M., Fiorillo, C., Stefani, M., Chiti, F., and Cecchi, C., “Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload.”, J Alzheimers Dis, vol. 60, no. 3, pp. 923-938, 2017.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., “Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
M. Ángel Ara Caballero, Klöppel, S., Dichgans, M., and Ewers, M., “Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects.”, J Alzheimers Dis, vol. 55, no. 1, pp. 343-358, 2017.
F. Carbonell, Zijdenbos, A. P., and Bedell, B. J., “Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 73, no. 2, pp. 543-557, 2019.
E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
C. Bussè, Anselmi, P., Pompanin, S., Zorzi, G., Fragiacomo, F., Camporese, G., Di Bernardo, G. Antonio, Semenza, C., Caffarra, P., and Cagnin, A., “Specific Verbal Memory Measures May Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1009-1015, 2017.
C. Bussè, Anselmi, P., Pompanin, S., Zorzi, G., Fragiacomo, F., Camporese, G., Di Bernardo, G. Antonio, Semenza, C., Caffarra, P., and Cagnin, A., “Specific Verbal Memory Measures May Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1009-1015, 2017.
C. Bussè, Anselmi, P., Pompanin, S., Zorzi, G., Fragiacomo, F., Camporese, G., Di Bernardo, G. Antonio, Semenza, C., Caffarra, P., and Cagnin, A., “Specific Verbal Memory Measures May Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1009-1015, 2017.
G. Chen, Shu, H., Chen, G., B Ward, D., Antuono, P. G., Zhang, Z., and Li, S. - J., “Staging Alzheimer's Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers.”, J Alzheimers Dis, vol. 54, no. 3, pp. 983-993, 2016.
G. Chen, Shu, H., Chen, G., B Ward, D., Antuono, P. G., Zhang, Z., and Li, S. - J., “Staging Alzheimer's Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers.”, J Alzheimers Dis, vol. 54, no. 3, pp. 983-993, 2016.
A. Chincarini, Sensi, F., Rei, L., Bossert, I., Morbelli, S., Guerra, U. Paolo, Frisoni, G., Padovani, A., and Nobili, F., “Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1437-1457, 2016.
V. K. Ramanan, Przybelski, S. A., Graff-Radford, J., Castillo, A. M., Lowe, V. J., Mielke, M. M., Roberts, R. O., Reid, R. I., Knopman, D. S., Jack, C. R., Petersen, R. C., and Vemuri, P., “Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1345-1352, 2018.
J. Myeong Kang, Yeon, B. Kil, Cho, S. - J., and Suh, Y. - H., “Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials.”, J Alzheimers Dis, vol. 54, no. 3, pp. 879-889, 2016.
B. Foveau, Correia, A. Sofia, Hébert, S. S., Rainone, S., Potvin, O., Kergoat, M. - J., Belleville, S., Duchesne, S., and LeBlanc, A. C., “Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 3, pp. 893-910, 2019.
F. Chao, Jiang, L., Zhang, Y., Zhou, C., Zhang, L., Tang, J., Liang, X., Qi, Y., Zhu, Y., Ma, J., and Tang, Y., “Stereological Investigation of the Effects of Treadmill Running Exercise on the Hippocampal Neurons in Middle-Aged APP/PS1 Transgenic Mice.”, J Alzheimers Dis, vol. 63, no. 2, pp. 689-703, 2018.
Y. - T. Dong, Cao, K., Tan, L. - C., Wang, X. - L., Qi, X. - L., Xiao, Y., and Guan, Z. - Z., “Stimulation of SIRT1 Attenuates the Level of Oxidative Stress in the Brains of APP/PS1 Double Transgenic Mice and in Primary Neurons Exposed to Oligomers of the Amyloid-β Peptide.”, J Alzheimers Dis, vol. 63, no. 1, pp. 283-301, 2018.
G. J. Kinsella, Ames, D., Storey, E., Ong, B., Pike, K. E., Saling, M. M., Clare, L., Mullaly, E., and Rand, E., “Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment.”, J Alzheimers Dis, vol. 49, no. 1, pp. 31-43, 2016.
D. Li, Huang, Y., Cheng, B., Su, J., Zhou, W. - X., and Zhang, Y. - X., “Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze.”, J Alzheimers Dis, vol. 54, no. 1, pp. 89-98, 2016.
C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S., “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S., “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.

Pages